Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...

Myeloid leukaemias are among the most aggressive blood cancers and have low survival rates. Today, leukaemia patients undergo ...

A study demonstrates that the 'previous state' of blood stem cells plays a decisive role in the subtype of leukemia that develops. The new technique, called STRACK, allows monitoring of the evolution ...

B-cell prolymphocytic leukemia (B-PLL) is a rare ... However, new targeted treatments in development may improve outcomes. This cancer affects immature cells in the immune system called ...

Their findings hold promise for advancing the development of preclinical tools ... uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the ...

Leukemic stem cells (LSCs) and stemness signatures contribute to minimal residual disease in patients with acute myeloid leukemia (AML), which is associated with an increased risk of relapse. The ...

Survival after the development of an accelerated ... Chronic myeloid leukemia (CML) is a myeloproliferative stem-cell disorder with a tri-phasic course, with a pathagnomonic t(9,22) giving rise ...